Chinese drugmaker Chipscreen’s STAR Market IPO sees feverish demand
Shenzhen Chipscreen
Biosciences, which plans to list on China’s red-hot new tech
board, said its newly issued shares were almost 3,000-times
oversubscribed among retail investors, despite an eye-popping
offer pricing of 468-times earnings.
Biosciences, which plans to list on China’s red-hot new tech
board, said its newly issued shares were almost 3,000-times
oversubscribed among retail investors, despite an eye-popping
offer pricing of 468-times earnings.
Posted by Reuters